ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,921Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 761

$818K Total Retail Price of All Prescriptions

Rank: 25 out of 761

676 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 676 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

20% of this provider’s 676 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 11,071 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 712 554 1 1
LEVOTHYROXINE SODIUM 585 443 2 3
HYDROCODONE-ACETAMINOPHEN 461 300 S3 3 5
AMLODIPINE BESYLATE 428 362 4 6
LOVASTATIN 400 306 5 17
SIMVASTATIN 352 303 6 2
WARFARIN SODIUM 351 297 7 9
ATORVASTATIN CALCIUM 334 285 8 12
OMEPRAZOLE 323 229 9 4
METFORMIN HCL 291 234 10 10
OXYCODONE HCL 285 131 S2 11 24
ATENOLOL 275 232 12 8
FUROSEMIDE 263 225 13 7
ZOLPIDEM TARTRATE 235 133 14 22
METOPROLOL TARTRATE 234 205 15 14
CITALOPRAM HBR 221 139 16 19
SERTRALINE HCL 206 192 17 25
GABAPENTIN 204 165 18 15
CARVEDILOL 183 127 19 26
POTASSIUM CHLORIDE 178 137 20 18
HYDROCHLOROTHIAZIDE 151 114 21 11
TRAZODONE HCL 144 81 22 23
PRAVASTATIN SODIUM 135 118 23 20
LANTUS SOLOSTAR 133 121 24 94
OXYCODONE-ACETAMINOPHEN 125 66 S2 25 49
METOPROLOL SUCCINATE 124 117 26 16
TERAZOSIN HCL 118 104 27 86
LOSARTAN POTASSIUM 118 108 27 13
BENICAR 117 117 29 81
LANTUS 117 55 29 41
TRAMADOL HCL 116 83 31 34
GLYBURIDE 111 94 R 32 77
GLIMEPIRIDE 107 87 33 48
RANITIDINE HCL 95 60 34 52
TAMSULOSIN HCL 92 81 35 27
SPIRIVA 90 71 36 56
METHADONE HCL 89 24 S2 37 75
CYMBALTA 87 30 38 53
CRESTOR 86 46 39 36
PROMETHAZINE HCL 82 15 R 40 104
FLUOXETINE HCL 80 49 41 31
FLUTICASONE PROPIONATE 79 68 42 29
NEXIUM 78 50 43 98
JANUVIA 75 60 44 113
PROPRANOLOL HCL 73 59 45 100
PAROXETINE HCL 72 45 46 47
ROPINIROLE HCL 70 59 47 95
AMITRIPTYLINE HCL 69 39 R 48 54
PROAIR HFA 67 43 49 32
MORPHINE SULFATE ER 67 18 S2 49 38
GLIPIZIDE 66 52 51 39
CYCLOBENZAPRINE HCL 66 18 R 51 51
TRICOR 66 50 51 164
DONEPEZIL HCL 65 65 54 33
FENTANYL 65 37 S2 54 57
ADVAIR DISKUS 65 46 54 37
BUPROPION XL 64 41 57 150
DIGOXIN 64 42 57 43
ALLOPURINOL 64 62 57 28
BUSPIRONE HCL 62 44 60 154
ACETAMINOPHEN-CODEINE 62 42 S3 60 118
LIPITOR 61 35 62 147
VERAPAMIL ER 61 42 62 109
ENALAPRIL MALEATE 59 38 64 71
POLYETHYLENE GLYCOL 3350 58 41 65 62
ESCITALOPRAM OXALATE 58 57 65 102
SPIRONOLACTONE 58 35 65 45
CLOPIDOGREL 57 51 68 66
ESTRADIOL 57 32 R 68 80
OXYCONTIN 55 31 S2 70 114
VENLAFAXINE HCL ER 55 37 70 76
CELEBREX 55 39 70 125
HUMALOG 55 49 70 123
PREDNISONE 55 49 70 30
ISOSORBIDE MONONITRATE ER 54 36 75 72
PANTOPRAZOLE SODIUM 53 49 76 40
KLOR-CON M10 52 44 77 197
ALENDRONATE SODIUM 52 51 77 21
SYNTHROID 52 40 77 64
OXYCODONE HCL-ACETAMINOPHEN 50 23 S2 80 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.